Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Flushing
ADR ID BADD_A01671
ADR Hierarchy
24      Vascular disorders
24.03      Vascular disorders NEC
24.03.01      Peripheral vascular disorders NEC
24.03.01.002      Flushing
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.03      General signs and symptoms NEC
08.01.03.025      Flushing
23      Skin and subcutaneous tissue disorders
23.06      Skin vascular abnormalities
23.06.05      Skin vasomotor conditions
23.06.05.003      Flushing
Description A disorder characterized by episodic reddening of the skin, especially face, neck, or chest. [CTCAE] A transient reddening of the face that may be due to fever, certain drugs, exertion, or stress. [MeSH]
MedDRA Code 10016825
MeSH ID D005483
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Facial flushing | Flushed | Flushed chest | Flushed face | Flushed skin | Flushing | Flushing of face | Generalised flushing | Gross flushing | Pallor and flushing | Skin flushed | Flushing aggravated | Generalized flushing | Flushings
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02349Verapamil hydrochloride--
BADD_D02351Vernakalant hydrochloride--
BADD_D02352Verteporfin--
BADD_D02362Vinflunine--
BADD_D02363Vinorelbine--
BADD_D02364Vinorelbine tartrate--
BADD_D02367Voltaren--
BADD_D02369Voriconazole--
BADD_D02371Vortioxetine--
BADD_D02372Vortioxetine hydrobromide--
BADD_D02378Zalcitabine--
BADD_D02392Zoledronic acid--
BADD_D02394Zolpidem--
BADD_D02395Zolpidem tartrate--
BADD_D02396Zonisamide0.000414%
BADD_D02412Octreotide0.003744%
BADD_D02418Doxylamine0.006036%
BADD_D02441Rasagiline0.001624%
BADD_D02445Solifenacin0.000260%
BADD_D02453Midostaurin0.000381%
BADD_D02462Methylnaltrexone0.000966%
BADD_D02464Fingolimod0.014684%
BADD_D02471Oxygen--
BADD_D02473Sodium chloride0.006565%
BADD_D02492Deflazacort0.000484%
BADD_D02493Selinexor0.000246%
BADD_D02503Telotristat ethyl-
BADD_D02508Edaravone0.001184%
BADD_D02536Bremelanotide0.000484%
BADD_D02539Calcium0.000861%
The 24th Page    First    Pre   24 25    Next   Last    Total 25 Pages
ADReCS-Target
ADR Term Drug Name Target